Global Controlled Release Drug Delivery Market Research Report - Global Forecast till 2032

Controlled Release Drug Delivery Market Research Report: Information By Route of Administration (Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, and Targeted Delivery), Release Mechanism (Polymer Based Systems, Micro Reservoir Partition Controlled Drug Delivery Systems, Feedback Regulated Drug Delivery Systems, Activation-modulated Drug Delivery Systems, and Chemically Activated), Application (Metered Dose Inhalers, Injectable, Transdermal and Ocular Patches, Infusion Pumps, Oral Controlled-drug delivery Systems

ID: MRFR/Pharma/5330-HCR | 90 Pages | Author: Rahul Gotadki | March 2024         

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Route of Administration Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Controlled Release Drug Delivery Market, by Route of Administration

6.1 Introduction

6.2 Oral

6.3 Injectable

6.3.1 Targeted Delivery

6.3.2 Transmucosal

6.3.3 Transdermal

6.4 Ocular

6.5 Nasal

6.6 Topical

6.7 Implantable

Chapter 7. Global Controlled Release Drug Delivery Market, by Release Mechanism

7.1 Introduction

7.2 Polymer-based Drug Delivery Systems

7.3 Micro reservoir Partition Controlled Drug Delivery Systems

7.4 Feedback Regulated Drug Delivery Systems

7.5 Activation Modulated Drug Delivery Systems

7.5.1 Osmotic Pressure Activated drug delivery

7.5.2 Hydrodynamic Pressure Activated drug delivery

7.5.3 Vapor Pressure Activated drug delivery

7.5.4 Mechanically Activated drug

7.5.5 Magnetically Activated drug

7.6 Chemically Activated Controlled Drug Delivery Systems

7.6.1 pH Activated Drug Delivery

7.6.2 Hydrolysis Activated Drug Delivery

7.6.3 Enzyme Activated Drug Delivery

Chapter 8. Global Controlled Release Drug Delivery Market, by Products

8.1 Metered Dose Inhalers,

8.2 Needle-Free injectors

8.3 Auto-injectors

8.4 Nasal sprays

8.5 Transdermal Patchez

8.6 Nebulizers

8.7 Infusion Pumps

8.8 Drug-Eluting Stents

8.9 Sustained Release

8.10 Ocular Implants

Chapter 9. Global Controlled Release Drug Delivery Market, by End User

9.1 Introduction

9.2 Hospital and Clinics

9.3 Personal Use

9.4 Research Centers

9.5 Others

Chapter 10. Global Controlled Release Drug Delivery Market, by Region

10.1 Introduction

10.2 America

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

10.6. Company Landscape

10.6.1 Introduction

10.6.2 Market Share Analysis

10.6.3 Key Development & Strategies

10.6.3.1 Key Developments

Chapter 11 Company Profiles

11.1 DEPOMED, INC.

11.1.1 Company Overview

11.1.2 Type Overview

11.1.3 Financials

11.2.4 Key Developments

11.1.5 SWOT Analysis

11.2 Coating Place, Inc

11.2.1 Company Overview

11.2.2 Type Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Corium International Inc.

11.3.1 Company Overview

11.3.2 Type Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Alza Corporation (Johnson & Johnson)

11.4.1 Company Overview

11.4.2 Type/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 PFIZER INC.

11.5.1 Company Overview

11.5.2 Type Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 SKY Pharmaceuticals Pvt. Ltd.

11.6.1 Company Overview

11.6.2 Type Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 AstraZeneca

11.7.1 Overview

11.7.2 Type Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 BIOGEN

11.8.1 Overview

11.8.2 Type Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 GlaxoSmithKline

11.9.1 Overview

11.9.2 Type Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Novartis

11.10.1 Overview

11.10.2 Type Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Allergan

11.11.1 Overview

11.11.2 Type Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 Collegium Pharmaceutical

11.11.1 Overview

11.11.2 Type Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.13 Others

Chapter 12 Appendix

LIST OF TABLES

Table 1 Global Controlled Release Drug Delivery Market Industry Synopsis, 2020–2027

Table 2 Global Controlled Release Drug Delivery Market Estimates & Forecast, 2020–2027, (USD Million)

Table 3 Global Controlled Release Drug Delivery Market, by Region, 2020–2027, (USD Million)

Table 4 Global Controlled Release Drug Delivery Market, by Route of Administration, 2020–2027, (USD Million)

Table 5 Global Controlled Release Drug Delivery Market, by Release Mechanism, 2020 –2027, (USD Million)

Table 6 Global Controlled Release Drug Delivery Market, by Products, 2020 –2027, (USD Million)

Table 7 Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)

Table 8 North America: Global Controlled Release Drug Delivery Market, by Route of Administration, 2020–2027, (USD Million)

Table 9 North America: Global Controlled Release Drug Delivery Market, by Release Mechanism, 2020 –2027, (USD Million)

Table 10 North America: Global Controlled Release Drug Delivery Market, by Products, 2020 –2027, (USD Million)

Table 11 North America: Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)

Table 12 US: Global Controlled Release Drug Delivery Market, by Route of Administration, 2020–2027, (USD Million)

Table 13 US: Global Controlled Release Drug Delivery Market, by Release Mechanism, 2020 –2027, (USD Million)

Table 14 US: Global Controlled Release Drug Delivery Market, by Products, 2020 –2027, (USD Million)

Table 15 US: Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)

Table 16 Canada: Global Controlled Release Drug Delivery Market, by Route of Administration, 2020–2027, (USD Million)

Table 17 Canada: Global Controlled Release Drug Delivery Market, by Release Mechanism, 2020 –2027, (USD Million)

Table 18 Canada: Global Controlled Release Drug Delivery Market, by Products, 2020 –2027, (USD Million)

Table 19 Canada: Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)

Table 20 South America: Global Controlled Release Drug Delivery Market, by Route of Administration, 2020–2027, (USD Million)

Table 21 South America: Global Controlled Release Drug Delivery Market, by Release Mechanism, 2020 –2027, (USD Million)

Table 22 South America: Global Controlled Release Drug Delivery Market, by Products, 2020 –2027, (USD Million

Table 23 South America: Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)

Table 24 Europe: Global Controlled Release Drug Delivery Market, Route of Administration, 2020–2027, (USD Million)

Table 25 Europe: Controlled Release Drug Delivery Market, by Release Mechanism, 2020 –2027, (USD Million)

Table 26 Europe: Controlled Release Drug Delivery Market, by Products, 2020 –2027, (USD Million)

Table 27 Europe: Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)

Table 28 Western Europe: Global Controlled Release Drug Delivery Market, by Route of Administration, 2020–2027, (USD Million)

Table 29 Western Europe: Global Controlled Release Drug Delivery Market, by Release Mechanism ,2020 –2027, (USD Million)

Table 30 Western Europe: Global Controlled Release Drug Delivery Market, by Products,2020 –2027, (USD Million)

Table 31 Western Europe: Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)

Table 32 Eastern Europe: Global Controlled Release Drug Delivery Market, by Route of Administration, 2020–2027, (USD Million)

Table 33 Eastern Europe: Global Controlled Release Drug Delivery Market, by Release Mechanism, 2020 –2027, (USD Million)

Table 34 Eastern Europe: Global Controlled Release Drug Delivery Market, by Patent Type, 2020 –2027, (USD Million)

Table 35 Eastern Europe: Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)

Table 36 Asia-Pacific: Global Controlled Release Drug Delivery Market, by Route of Administration, 2020–2027, (USD Million)

Table 37 Asia-Pacific: Global Controlled Release Drug Delivery Market, by Release Mechanism, 2020 –2027, (USD Million)

Table 38 Asia-Pacific: Global Controlled Release Drug Delivery Market, by Products, 2020 –2027, (USD Million)

Table 39 Asia-Pacific: Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)

Table 40 Middle East & Africa: Global Controlled Release Drug Delivery Market, by Route of Administration, 2020–2027, (USD Million)

Table 41 Middle East & Africa: Global Controlled Release Drug Delivery Market, by Release Mechanism, 2020 –2027, (USD Million)

Table 42 Middle East & Africa: Global Controlled Release Drug Delivery Market, by Products, 2020 –2027, (USD Million)

Table 43 Middle East & Africa: Global Controlled Release Drug Delivery Market, by End-User, 2020–2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Products

Figure 2 Market structure for the Global Controlled Release Drug Delivery Market

Figure 3 Market Dynamics for the Global Controlled Release Drug Delivery Market

Figure 4 Global Controlled Release Drug Delivery Market Share, by Route of Administration 2020

Figure 5 Global Controlled Release Drug Delivery Market Share, by Release Mechanism, 2020

Figure 6 Global Controlled Release Drug Delivery Market Share, by Products, 2020

Figure 7 Global Controlled Release Drug Delivery Market Share, by End-User, 2020

Figure 8 Global Controlled Release Drug Delivery Market Share, by Region, 2020

Figure 9 North America Global Controlled Release Drug Delivery Market Share, by Country, 2020

Figure 10 Europe Prescribed Health Apps Share, by Country, 2020

Figure 11 Asia-Pacific Global Controlled Release Drug Delivery Market Share, by Country, 2020

Figure 12 Middle East & Africa Global Controlled Release Drug Delivery Market Share, by Country, 2020

Figure 13 Global Controlled Release Drug Delivery Market: Company Share Analysis, 2020 (%)

Figure 14 DEPOMED, INC.: Key Financials

Figure 15 DEPOMED, INC.: Segmental Revenue

Figure 16 DEPOMED, INC.: Geographical Revenue

Figure 17 Coating Place, Inc: Key Financials

Figure 18 Coating Place, Inc: Segmental Revenue

Figure 19 Coating Place, Inc: Geographical Revenue

Figure 20 Corium International Inc.: Key Financials

Figure 21 Corium International Inc.: Segmental Revenue

Figure 22 Corium International Inc.: Geographical Revenue

Figure 23 Alza Corporation (Johnson & Johnson): Key Financials

Figure 24 Alza Corporation (Johnson & Johnson): Segmental Revenue

Figure 25 Alza Corporation (Johnson & Johnson): Geographical Revenue

Figure 26 PFIZER INC.: Key Financials

Figure 27 PFIZER INC.: Segmental Revenue

Figure 28 PFIZER INC.: Geographical Revenue

Figure 29 SKY Pharmaceuticals Pvt. Ltd.: Key Financials

Figure 30 SKY Pharmaceuticals Pvt. Ltd.: Segmental Revenue

Figure 31 SKY Pharmaceuticals Pvt. Ltd.: Geographical Revenue

Figure 32 AstraZeneca: Key Financials

Figure 33 AstraZeneca: Segmental Revenue

Figure 34 AstraZeneca: Geographical Revenue

Figure 35 Biogen: Key Financials

Figure 36 Biogen: Segmental Revenue

Figure 37 Biogen: Geographical Revenue

Figure 38 GlaxoSmithKline: Key Financials

Figure 39 GlaxoSmithKline: Segmental Revenue

Figure 40 GlaxoSmithKline: Geographical Revenue

Figure 41 Novartis: Key Financials

Figure 42 Novartis: Segmental Revenue

Figure 43 Novartis: Geographical Revenue

Figure 44 Allergan: Key Financials

Figure 45 Allergan: Segmental Revenue

Figure 46 Allergan: Geographical Revenue

Figure 47 Collegium Pharmaceutical: Key Financials

Figure 48 Collegium Pharmaceutical: Segmental Revenue

Figure 49 Collegium Pharmaceutical: Geographical Revenue

Market Segmentation


Controlled Release Drug Delivery Route Of Administration Outlook (USD Billion, 2018-2032)




  • Wurster Technique




  • Coacervation




  • Micro Encapsulation




  • Implants




  • Transdermal




  • Targeted Delivery




Controlled Release Drug Delivery Release Mechanism Outlook (USD Billion, 2018-2032)




  • Polymer Based Systems




  • Micro Reservoir Partition Controlled Drug Delivery Systems




  • Feedback Regulated Drug Delivery Systems




  • Activation-modulated Drug Delivery Systems




  • Chemically Activated




Controlled Release Drug Delivery Application Outlook (USD Billion, 2018-2032)




  • Metered Dose Inhalers




  • Injectable




  • Transdermal




  • Ocular Patches




  • Infusion Pumps




  • Oral Controlled-drug delivery Systems




  • Drug Eluting Stents




Controlled Release Drug Delivery Regional Outlook (USD Billion, 2018-2032)




  • North America Outlook (USD Billion, 2018-2032)




    • North America Controlled Release Drug Delivery by Route Of Administration




      • Wurster Technique




      • Coacervation




      • Micro Encapsulation




      • Implants




      • Transdermal




      • Targeted Delivery






    • North America Controlled Release Drug Delivery by Release Mechanism




      • Polymer Based Systems




      • Micro Reservoir Partition Controlled Drug Delivery Systems




      • Feedback Regulated Drug Delivery Systems




      • Activation-modulated Drug Delivery Systems




      • Chemically Activated






    • North America Controlled Release Drug Delivery by Application




      • Metered Dose Inhalers




      • Injectable




      • Transdermal




      • Ocular Patches




      • Infusion Pumps




      • Oral Controlled-drug delivery Systems




      • Drug Eluting Stents






    • US Outlook (USD Billion, 2018-2032)




    • US Controlled Release Drug Delivery by Route Of Administration




      • Wurster Technique




      • Coacervation




      • Micro Encapsulation




      • Implants




      • Transdermal




      • Targeted Delivery






    • US Controlled Release Drug Delivery by Release Mechanism




      • Polymer Based Systems




      • Micro Reservoir Partition Controlled Drug Delivery Systems




      • Feedback Regulated Drug Delivery Systems




      • Activation-modulated Drug Delivery Systems




      • Chemically Activated






    • US Controlled Release Drug Delivery by Application




      • Metered Dose Inhalers




      • Injectable




      • Transdermal




      • Ocular Patches




      • Infusion Pumps




      • Oral Controlled-drug delivery Systems




      • Drug Eluting Stents






    • CANADA Outlook (USD Billion, 2018-2032)




    • CANADA Controlled Release Drug Delivery by Route Of Administration




      • Wurster Technique




      • Coacervation




      • Micro Encapsulation




      • Implants




      • Transdermal




      • Targeted Delivery






    • CANADA Controlled Release Drug Delivery by Release Mechanism




      • Polymer Based Systems




      • Micro Reservoir Partition Controlled Drug Delivery Systems




      • Feedback Regulated Drug Delivery Systems




      • Activation-modulated Drug Delivery Systems




      • Chemically Activated






    • CANADA Controlled Release Drug Delivery by Application




      • Metered Dose Inhalers




      • Injectable




      • Transdermal




      • Ocular Patches




      • Infusion Pumps




      • Oral Controlled-drug delivery Systems




      • Drug Eluting Stents








  • Europe Outlook (USD Billion, 2018-2032)




    • Europe Controlled Release Drug Delivery by Route Of Administration




      • Wurster Technique




      • Coacervation




      • Micro Encapsulation




      • Implants




      • Transdermal




      • Targeted Delivery






    • Europe Controlled Release Drug Delivery by Release Mechanism




      • Polymer Based Systems




      • Micro Reservoir Partition Controlled Drug Delivery Systems




      • Feedback Regulated Drug Delivery Systems




      • Activation-modulated Drug Delivery Systems




      • Chemically Activated






    • Europe Controlled Release Drug Delivery by Application




      • Metered Dose Inhalers




      • Injectable




      • Transdermal




      • Ocular Patches




      • Infusion Pumps




      • Oral Controlled-drug delivery Systems




      • Drug Eluting Stents






    • Germany Outlook (USD Billion, 2018-2032)




    • Germany Controlled Release Drug Delivery by Route Of Administration




      • Wurster Technique




      • Coacervation




      • Micro Encapsulation




      • Implants




      • Transdermal




      • Targeted Delivery






    • Germany Controlled Release Drug Delivery by Release Mechanism




      • Polymer Based Systems




      • Micro Reservoir Partition Controlled Drug Delivery Systems




      • Feedback Regulated Drug Delivery Systems




      • Activation-modulated Drug Delivery Systems




      • Chemically Activated






    • Germany Controlled Release Drug Delivery by Application




      • Metered Dose Inhalers




      • Injectable




      • Transdermal




      • Ocular Patches




      • Infusion Pumps




      • Oral Controlled-drug delivery Systems




      • Drug Eluting Stents






    • France Outlook (USD Billion, 2018-2032)




    • France Controlled Release Drug Delivery by Route Of Administration




      • Wurster Technique




      • Coacervation




      • Micro Encapsulation




      • Implants




      • Transdermal




      • Targeted Delivery






    • France Controlled Release Drug Delivery by Release Mechanism




      • Polymer Based Systems




      • Micro Reservoir Partition Controlled Drug Delivery Systems




      • Feedback Regulated Drug Delivery Systems




      • Activation-modulated Drug Delivery Systems




      • Chemically Activated






    • France Controlled Release Drug Delivery by Application




      • Metered Dose Inhalers




      • Injectable




      • Transdermal




      • Ocular Patches




      • Infusion Pumps




      • Oral Controlled-drug delivery Systems




      • Drug Eluting Stents






    • UK Outlook (USD Billion, 2018-2032)




    • UK Controlled Release Drug Delivery by Route Of Administration




      • Wurster Technique




      • Coacervation




      • Micro Encapsulation




      • Implants




      • Transdermal




      • Targeted Delivery






    • UK Controlled Release Drug Delivery by Release Mechanism




      • Polymer Based Systems




      • Micro Reservoir Partition Controlled Drug Delivery Systems




      • Feedback Regulated Drug Delivery Systems




      • Activation-modulated Drug Delivery Systems




      • Chemically Activated






    • UK Controlled Release Drug Delivery by Application




      • Metered Dose Inhalers




      • Injectable




      • Transdermal




      • Ocular Patches




      • Infusion Pumps




      • Oral Controlled-drug delivery Systems




      • Drug Eluting Stents






    • ITALY Outlook (USD Billion, 2018-2032)




    • ITALY Controlled Release Drug Delivery by Route Of Administration




      • Wurster Technique




      • Coacervation




      • Micro Encapsulation




      • Implants




      • Transdermal




      • Targeted Delivery






    • ITALY Controlled Release Drug Delivery by Release Mechanism




      • Polymer Based Systems




      • Micro Reservoir Partition Controlled Drug Delivery Systems




      • Feedback Regulated Drug Delivery Systems




      • Activation-modulated Drug Delivery Systems




      • Chemically Activated






    • ITALY Controlled Release Drug Delivery by Application




      • Metered Dose Inhalers




      • Injectable




      • Transdermal




      • Ocular Patches




      • Infusion Pumps




      • Oral Controlled-drug delivery Systems




      • Drug Eluting Stents






    • SPAIN Outlook (USD Billion, 2018-2032)




    • Spain Controlled Release Drug Delivery by Route Of Administration




      • Wurster Technique




      • Coacervation




      • Micro Encapsulation




      • Implants




      • Transdermal




      • Targeted Delivery






    • Spain Controlled Release Drug Delivery by Release Mechanism




      • Polymer Based Systems




      • Micro Reservoir Partition Controlled Drug Delivery Systems




      • Feedback Regulated Drug Delivery Systems




      • Activation-modulated Drug Delivery Systems




      • Chemically Activated






    • Spain Controlled Release Drug Delivery by Application




      • Metered Dose Inhalers




      • Injectable




      • Transdermal




      • Ocular Patches




      • Infusion Pumps




      • Oral Controlled-drug delivery Systems




      • Drug Eluting Stents






    • Rest Of Europe Outlook (USD Billion, 2018-2032)




    • Rest Of Europe Controlled Release Drug Delivery by Route Of Administration




      • Wurster Technique




      • Coacervation




      • Micro Encapsulation




      • Implants




      • Transdermal




      • Targeted Delivery






    • Rest Of Europe Controlled Release Drug Delivery by Release Mechanism




      • Polymer Based Systems




      • Micro Reservoir Partition Controlled Drug Delivery Systems




      • Feedback Regulated Drug Delivery Systems




      • Activation-modulated Drug Delivery Systems




      • Chemically Activated






    • Rest Of Europe Controlled Release Drug Delivery by Application




      • Metered Dose Inhalers




      • Injectable




      • Transdermal




      • Ocular Patches




      • Infusion Pumps




      • Oral Controlled-drug delivery Systems




      • Drug Eluting Stents








  • Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Asia-Pacific Controlled Release Drug Delivery by Route Of Administration




      • Wurster Technique




      • Coacervation




      • Micro Encapsulation




      • Implants




      • Transdermal




      • Targeted Delivery






    • Asia-Pacific Controlled Release Drug Delivery by Release Mechanism




      • Polymer Based Systems




      • Micro Reservoir Partition Controlled Drug Delivery Systems




      • Feedback Regulated Drug Delivery Systems




      • Activation-modulated Drug Delivery Systems




      • Chemically Activated






    • Asia-Pacific Controlled Release Drug Delivery by Application




      • Metered Dose Inhalers




      • Injectable




      • Transdermal




      • Ocular Patches




      • Infusion Pumps




      • Oral Controlled-drug delivery Systems




      • Drug Eluting Stents






    • China Outlook (USD Billion, 2018-2032)




    • China Controlled Release Drug Delivery by Route Of Administration




      • Wurster Technique




      • Coacervation




      • Micro Encapsulation




      • Implants




      • Transdermal




      • Targeted Delivery






    • China Controlled Release Drug Delivery by Release Mechanism




      • Polymer Based Systems




      • Micro Reservoir Partition Controlled Drug Delivery Systems




      • Feedback Regulated Drug Delivery Systems




      • Activation-modulated Drug Delivery Systems




      • Chemically Activated






    • China Controlled Release Drug Delivery by Application




      • Metered Dose Inhalers




      • Injectable




      • Transdermal




      • Ocular Patches




      • Infusion Pumps




      • Oral Controlled-drug delivery Systems




      • Drug Eluting Stents






    • Japan Outlook (USD Billion, 2018-2032)




    • Japan Controlled Release Drug Delivery by Route Of Administration




      • Wurster Technique




      • Coacervation




      • Micro Encapsulation




      • Implants




      • Transdermal




      • Targeted Delivery






    • Japan Controlled Release Drug Delivery by Release Mechanism




      • Polymer Based Systems




      • Micro Reservoir Partition Controlled Drug Delivery Systems




      • Feedback Regulated Drug Delivery Systems




      • Activation-modulated Drug Delivery Systems




      • Chemically Activated






    • Japan Controlled Release Drug Delivery by Application




      • Metered Dose Inhalers




      • Injectable




      • Transdermal




      • Ocular Patches




      • Infusion Pumps




      • Oral Controlled-drug delivery Systems




      • Drug Eluting Stents






    • India Outlook (USD Billion, 2018-2032)




    • India Controlled Release Drug Delivery by Route Of Administration




      • Wurster Technique




      • Coacervation




      • Micro Encapsulation




      • Implants




      • Transdermal




      • Targeted Delivery






    • India Controlled Release Drug Delivery by Release Mechanism




      • Polymer Based Systems




      • Micro Reservoir Partition Controlled Drug Delivery Systems




      • Feedback Regulated Drug Delivery Systems




      • Activation-modulated Drug Delivery Systems




      • Chemically Activated






    • India Controlled Release Drug Delivery by Application




      • Metered Dose Inhalers




      • Injectable




      • Transdermal




      • Ocular Patches




      • Infusion Pumps




      • Oral Controlled-drug delivery Systems




      • Drug Eluting Stents






    • Australia Outlook (USD Billion, 2018-2032)




    • Australia Controlled Release Drug Delivery by Route Of Administration




      • Wurster Technique




      • Coacervation




      • Micro Encapsulation




      • Implants




      • Transdermal




      • Targeted Delivery






    • Australia Controlled Release Drug Delivery by Release Mechanism




      • Polymer Based Systems




      • Micro Reservoir Partition Controlled Drug Delivery Systems




      • Feedback Regulated Drug Delivery Systems




      • Activation-modulated Drug Delivery Systems




      • Chemically Activated






    • Australia Controlled Release Drug Delivery by Application




      • Metered Dose Inhalers




      • Injectable




      • Transdermal




      • Ocular Patches




      • Infusion Pumps




      • Oral Controlled-drug delivery Systems




      • Drug Eluting Stents






    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)




    • Rest of Asia-Pacific Controlled Release Drug Delivery by Route Of Administration




      • Wurster Technique




      • Coacervation




      • Micro Encapsulation




      • Implants




      • Transdermal




      • Targeted Delivery






    • Rest of Asia-Pacific Controlled Release Drug Delivery by Release Mechanism




      • Polymer Based Systems




      • Micro Reservoir Partition Controlled Drug Delivery Systems




      • Feedback Regulated Drug Delivery Systems




      • Activation-modulated Drug Delivery Systems




      • Chemically Activated






    • Rest of Asia-Pacific Controlled Release Drug Delivery by Application




      • Metered Dose Inhalers




      • Injectable




      • Transdermal




      • Ocular Patches




      • Infusion Pumps




      • Oral Controlled-drug delivery Systems




      • Drug Eluting Stents








  • Rest of the World Outlook (USD Billion, 2018-2032)




    • Rest of the World Controlled Release Drug Delivery by Route Of Administration




      • Wurster Technique




      • Coacervation




      • Micro Encapsulation




      • Implants




      • Transdermal




      • Targeted Delivery






    • Rest of the World Controlled Release Drug Delivery by Release Mechanism




      • Polymer Based Systems




      • Micro Reservoir Partition Controlled Drug Delivery Systems




      • Feedback Regulated Drug Delivery Systems




      • Activation-modulated Drug Delivery Systems




      • Chemically Activated






    • Rest of the World Controlled Release Drug Delivery by Application




      • Metered Dose Inhalers




      • Injectable




      • Transdermal




      • Ocular Patches




      • Infusion Pumps




      • Oral Controlled-drug delivery Systems




      • Drug Eluting Stents






    • Middle East Outlook (USD Billion, 2018-2032)




    • Middle East Controlled Release Drug Delivery by Route Of Administration




      • Wurster Technique




      • Coacervation




      • Micro Encapsulation




      • Implants




      • Transdermal




      • Targeted Delivery






    • Middle East Controlled Release Drug Delivery by Release Mechanism




      • Polymer Based Systems




      • Micro Reservoir Partition Controlled Drug Delivery Systems




      • Feedback Regulated Drug Delivery Systems




      • Activation-modulated Drug Delivery Systems




      • Chemically Activated






    • Middle East Controlled Release Drug Delivery by Application




      • Metered Dose Inhalers




      • Injectable




      • Transdermal




      • Ocular Patches




      • Infusion Pumps




      • Oral Controlled-drug delivery Systems




      • Drug Eluting Stents






    • Africa Outlook (USD Billion, 2018-2032)




    • Africa Controlled Release Drug Delivery by Route Of Administration




      • Wurster Technique




      • Coacervation




      • Micro Encapsulation




      • Implants




      • Transdermal




      • Targeted Delivery






    • Africa Controlled Release Drug Delivery by Release Mechanism




      • Polymer Based Systems




      • Micro Reservoir Partition Controlled Drug Delivery Systems




      • Feedback Regulated Drug Delivery Systems




      • Activation-modulated Drug Delivery Systems




      • Chemically Activated






    • Africa Controlled Release Drug Delivery by Application




      • Metered Dose Inhalers




      • Injectable




      • Transdermal




      • Ocular Patches




      • Infusion Pumps




      • Oral Controlled-drug delivery Systems




      • Drug Eluting Stents






    • Latin America Outlook (USD Billion, 2018-2032)




    • Latin America Controlled Release Drug Delivery by Route Of Administration




      • Wurster Technique




      • Coacervation




      • Micro Encapsulation




      • Implants




      • Transdermal




      • Targeted Delivery






    • Latin America Controlled Release Drug Delivery by Release Mechanism




      • Polymer Based Systems




      • Micro Reservoir Partition Controlled Drug Delivery Systems




      • Feedback Regulated Drug Delivery Systems




      • Activation-modulated Drug Delivery Systems




      • Chemically Activated






    • Latin America Controlled Release Drug Delivery by Application




      • Metered Dose Inhalers




      • Injectable




      • Transdermal




      • Ocular Patches




      • Infusion Pumps




      • Oral Controlled-drug delivery Systems




      • Drug Eluting Stents







Leading companies partner with us for data-driven Insights.
Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid